EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,060,000 | +52.3% | 23,864 | +69.7% | 0.00% | – |
| Q1 2022 | $696,000 | +42.9% | 14,064 | +47.2% | 0.00% | – |
| Q4 2021 | $487,000 | -8.6% | 9,557 | 0.0% | 0.00% | – |
| Q3 2021 | $533,000 | +30.3% | 9,557 | 0.0% | 0.00% | – |
| Q2 2021 | $409,000 | +46.6% | 9,557 | +43.2% | 0.00% | – |
| Q1 2021 | $279,000 | -33.4% | 6,673 | -25.9% | 0.00% | – |
| Q4 2020 | $419,000 | +9.1% | 9,005 | -0.3% | 0.00% | – |
| Q3 2020 | $384,000 | -44.2% | 9,036 | -37.0% | 0.00% | -100.0% |
| Q2 2020 | $688,000 | +4.4% | 14,336 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $659,000 | -23.5% | 14,336 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $861,000 | -14.7% | 14,336 | -19.7% | 0.00% | 0.0% |
| Q3 2019 | $1,009,000 | +1.6% | 17,843 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $993,000 | -39.0% | 17,843 | -50.2% | 0.00% | 0.0% |
| Q1 2019 | $1,627,000 | +125.3% | 35,859 | +100.1% | 0.00% | 0.0% |
| Q4 2018 | $722,000 | -41.9% | 17,925 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,243,000 | -20.8% | 17,925 | -13.6% | 0.00% | 0.0% |
| Q2 2018 | $1,570,000 | +0.1% | 20,752 | -30.3% | 0.00% | 0.0% |
| Q1 2018 | $1,569,000 | -1.4% | 29,784 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,591,000 | +11.5% | 29,784 | +24.5% | 0.00% | 0.0% |
| Q3 2017 | $1,427,000 | +63.8% | 23,921 | +116.6% | 0.00% | +100.0% |
| Q2 2017 | $871,000 | +36.7% | 11,045 | +43.8% | 0.00% | 0.0% |
| Q1 2017 | $637,000 | +38.8% | 7,680 | +32.9% | 0.00% | 0.0% |
| Q4 2016 | $459,000 | -31.4% | 5,780 | -39.5% | 0.00% | 0.0% |
| Q3 2016 | $669,000 | +20.5% | 9,550 | -23.4% | 0.00% | 0.0% |
| Q2 2016 | $555,000 | +19.6% | 12,461 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $464,000 | -58.0% | 12,461 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,105,000 | +19.8% | 12,461 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $922,000 | – | 12,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |